Affordable Insulin Now Act
Latest action · Feb 17, 2022 Read twice and referred to the Committee on Finance.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 17, 2022
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Affordable Insulin Now Act
This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023.
The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill.
Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.
Cosponsors 36
Members who signed on, in the order they did. Signatures ran from Feb 17, 2022 to Apr 26, 2022; 19 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-CA | Alex Padilla | Original | Feb 17, 2022 |
| D-MN | Amy Klobuchar | Original | Feb 17, 2022 |
| I-ME | Angus S. King Jr. | Original | Feb 17, 2022 |
| D-NY | Charles E. Schumer | Original | Feb 17, 2022 |
| D-MD | Chris Van Hollen | Original | Feb 17, 2022 |
| D-CT | Christopher Murphy | Original | Feb 17, 2022 |
| D-NJ | Cory A. Booker | Original | Feb 17, 2022 |
| D-MI | Debbie Stabenow | Original | Feb 17, 2022 |
| D-RI | Jack Reed | Original | Feb 17, 2022 |
| D-NH | Jeanne Shaheen | Original | Feb 17, 2022 |
| D-NH | Margaret Wood Hassan | Original | Feb 17, 2022 |
| D-AZ | Mark Kelly | Original | Feb 17, 2022 |
| D-HI | Mazie K. Hirono | Original | Feb 17, 2022 |
| D-CO | Michael F. Bennet | Original | Feb 17, 2022 |
| D-CT | Richard Blumenthal | Original | Feb 17, 2022 |
| D-IL | Richard J. Durbin | Original | Feb 17, 2022 |
| D-OR | Ron Wyden | Original | Feb 17, 2022 |
| D-WI | Tammy Baldwin | Original | Feb 17, 2022 |
| D-MN | Tina Smith | Original | Feb 17, 2022 |
| D-NV | Catherine Cortez Masto | Mar 2, 2022 | |
| D-MI | Gary C. Peters | Mar 2, 2022 | |
| D-NV | Jacky Rosen | Mar 2, 2022 | |
| D-WV | Joe Manchin III | Mar 2, 2022 | |
| D-RI | Sheldon Whitehouse | Mar 2, 2022 | |
| D-OH | Sherrod Brown | Mar 2, 2022 | |
| D-OR | Jeff Merkley | Mar 8, 2022 | |
| D-CO | John W. Hickenlooper | Mar 10, 2022 | |
| D-NJ | Robert Menendez | Mar 10, 2022 | |
| D-PA | Robert P. Casey Jr. | Mar 10, 2022 | |
| I-AZ | Kyrsten Sinema | Mar 17, 2022 | |
| D-IL | Tammy Duckworth | Mar 22, 2022 | |
| D-NM | Martin Heinrich | Mar 23, 2022 | |
| D-CA | Dianne Feinstein | Mar 29, 2022 | |
| D-VA | Tim Kaine | Mar 29, 2022 | |
| D-NM | Ben Ray Luján | Apr 26, 2022 | |
| D-DE | Thomas R. Carper | Apr 26, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Finance Committee | Referred Feb 17, 2022 |
Actions 2
Everything that happened, newest first.
- Feb 17, 2022Introduced in Senate
- Feb 17, 2022Read twice and referred to the Committee on Finance.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S2345 | Richard J. Durbin D-IL | May 5, 2022 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R47409 | Insulin Coverage Under Private Health Insurance and Medicare Part D: In Brief | Report | Feb 6, 2023 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 6833 | Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 | Related bill | Sep 30, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans.
- Short Title(s) as Introduced
- Affordable Insulin Now Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 17, 2022Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.